RegulatoryRegulatoryPHN-03102026-10-05 08:02 CT
FDA Seeks Public Input to Support Ibogaine Research
Source · FDA press releases
TLDR
The FDA announced a request for information on approaches it is considering for designing early-phase clinical trials of ibogaine drug products. The agency is seeking public input on those approaches.
01—Key points
- 01The request concerns early-phase clinical trial design.
- 02The FDA is inviting public input on approaches under consideration.
Why it matters Editorial
Public input could inform the FDA’s consideration of approaches to early-phase ibogaine trials.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.